Survival advantage associated with multimodal therapy in women with node‐positive (stage‐IIIC) uterine papillary serous carcinoma: a National Cancer Database study von Lin, JF, Muñiz, K, Sukumvanich, P, Gehrig, P, Beriwal, S, Kelley, JL, Edwards, RP, Olawaiye, AB

Volltext

International radical trachelectomy assessment: IRTA study von Salvo, G, Ramirez, PT, Leitao, M, Cibula, D, Fotopoulou, C, Kucukmetin, A, Rendon, G, Perrotta, M, Ribeiro, R, Vieira, M, Baiocchi, G, Falconer, H, Persson, J, Wu, XH, Capilna, ME, Ioanid, N, Mosgaard, BJ, Berlev, I, Kaidarova, D, Olawaiye, AB, Liu, KJ, Nobre, SP, Kocian, R, Saso, S, Rundle, S, Noll, F, Tsunoda, AT, Palsdottir, K, Li, XQ, Ulrikh, E, Hu, ZJ, Pareja, R

Volltext

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era von Berger, Jessica L, Smith, Ashlee, Zorn, Kristin K, Sukumvanich, Paniti, Olawaiye, Alexander B, Kelley, Joseph, Krivak, Thomas C

Volltext

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity von Laskey, Robin A, Richard, Scott D, Smith, Ashlee L, Lin, Jeff F, Beck, Tiffany L, Lesnock, Jamie L, Kelley, 3rd, Joseph L, Olawaiye, Alexander B, Sukumvanich, Paniti, Krivak, Thomas C

Volltext

Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer von Rauh‐Hain, JA, del Carmen, M, Horowitz, NS, Alarcon, IA, Ko, E, Goodman, AK, Olawaiye, AB

Volltext